Umit Tapan, MD, David Hughes, PharmD, BCOP, Jasmine Patel, PharmD, BCOP and Bhavesh Shah, RPh, BCOP Receive Grant From Pfizer


Congratulations to Umit Tapan, MD, David Hughes, PharmD, BCOP, Jasmine Patel, PharmD, BCOP, and Bhavesh Shah, RPh, BCOP, who received a grant for $250,000 through Pfizer for “Improving Biomarker Driven Precision Therapy in NSCLC: The Importance of an Integrated Multidisciplinary Approach” last week. This was part of a competitive grant process through Pfizer that was awarded to only two centers across the United States. This initiative is comprised of an education series over the next two years, primarily focused on addressing racial and socioeconomic disparities that impede access to healthcare. It will focus on three key areas:

  1. Best practices for optimal biomarker testing in NSCLC and the need to understand barriers impeding testing
  2. Understanding new/novel targeted therapies for NSCLC including clinical data to direct treatment decisions
  3. Management of treatment-related toxicities that limit clinical benefit and may negatively impact quality of life

The unique aspects of BU/BMC’s patient population, multi-disciplinary thoracic oncology team (comprised of oncologists, molecular pathologists, interventional radiologists, pharmacists), and our embedded specialty pharmacy services will provide realistic approaches to optimal management for metastatic NSCLC.